Emily Y Jen

4PUBLICATIONS
25CO-AUTHORS
Molecular targetsMedical bacteriologyMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 09, 2025
Advancing drug development in myelodysplastic syndromes.

Alain Mina, Kathy L McGraw, Lea Cunningham

|Mar 09, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective.

Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon

|Jan 23, 2023
Considerations for Drug Development in Myelodysplastic Syndromes.

Mikkael A Sekeres, Nina Kim, Amy E DeZern

|Mar 24, 2022
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy.

Emily Y Jen, Xin Wang, Meng Li

Pageof 1